392 computer-security-"https:"-"https:"-"https:"-"https:"-"https:" positions at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
to your career stage; the ability to develop and lead an independent research programme, have awareness of an ethical and inclusive research culture, and secure research funding; a commitment to teaching
-
associated with a Tutorial Fellowship at St John’s College. This is an exciting opportunity to lead a world-class research programme in collider physics. The position is available from 1 September 2026
-
team in wide collaboration. OpenSAFELY is a highly secure, modular, open-source data analysis platform, combining best practice from both academia and the open-source software community. It is deployed
-
mail and deliveries, or assisting with small administrative tasks. You will also contribute to maintaining a safe and secure environment and may be required to train as a first aider or fire marshal. As
-
nucleotides, including their metabolism and roles in mutagenesis and cancer development. You will be responsible for undertaking a research programme using a wide range of biochemical and molecular biology
-
policies, and an annual programme of wellbeing events, including induction sessions on Welfare, Consent, and Equality, Diversity & Inclusion. You will represent the College at University-wide welfare forums
-
during field trials; working with on-site teams to oversee robotic platforms from both a technical and health and safety standpoint. For more information about the ORI, please see: ori.ox.ac.uk Informal
-
competitive programme of research and teaching. Applications are invited for the post of Climax Research Professor of Regulatory Innovation. This post is hosted by the Nuffield Department of Orthopaedics
-
schools in the world, rooted in the global excellence and centuries-old traditions of the University of Oxford. With more than £100m secured in philanthropic income in the past six years, our Development
-
an active programme of phase I, II, clinical trials across the UK, and Gambia, Burkina Faso and Kenya, working closely with international partners to evaluate vaccine safety, immune responses. We are now